Pan-Chyr Yang

This inventor holds 31 USPTO granted patents and 9 published patent applications and 5 EPO patents. Top assignees: National Taiwan University, Academia Sinica, Advpharma, Inc.. Active years: 1998-2024.

USPTO Granted Patents = 31 (Patent Applications = 9)

% Patents Active = 64.5

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 53(Granted Patents)

Company Filing History:

21 out of 1,388

National Taiwan University

National Health Research Institutes

patents

5. 1 out of 126

National Chung Hsing University

patents

6. 1 out of 1,241

National Yang Ming Chiao Tung University

patents

7. 1 out of 22

Taichung Veterans General Hospital

patents

8. 1 out of 145

Taipei Medical University

patents

9. 1 out of 1,322

The University of North Carolina at Chapel Hill

patents

10. 1 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2024

Loading Chart...

Areas of Expertise:

Cancer Treatment

Lung Cancer

Biomarkers

Aptamers

In Vitro Cell Culture

Metasurface Devices

Anticancer Agents

MicroRNA

Gene Profiling

Pharmaceutical Compositions

EGFR Silencing

Antimicrobial Susceptibility

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12109207 - Methods of using 4(1)-quinolone derivatives (2024-10-08),

2. 12085570 - Biomarkers for lung cancer stem cells (2024-09-10),

3. 12013513 - Metasurface based device for generating abrupt autofocusing beam (2024-06-18),

4. 11919886 - 4,9-dioxo-4,9-dihydronaphtho[2,3-B]furan-3-carboxamide derivatives and uses thereof for treating proliferative diseases and infectious diseases (2024-03-05),

5. 11891447 - Method for treating cancer using CD14 antagonists (2024-02-06),

6. 11834682 - Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness (2023-12-05),

7. 11638705 - 4(1H)-quinolone derivatives and uses thereof (2023-05-02),

8. 11447778 - TNF-targeting aptamers and uses thereof for treatment or diagnosing TNF-related inflammatory diseases (2022-09-20),

9. 11434229 - 4,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-3-carboxamide derivatives and uses thereof for treating proliferative diseases and infectious diseases (2022-09-06),

10. 11214774 - PINK1 C-terminal domain polypeptide and methods using the same in cancer treatment (2022-01-04),

11. 10888568 - Pharmaceutical composition for treatment of cancer using phenothiazine (2021-01-12),

12. 10865388 - Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness (2020-12-15),

13. 10765681 - Purine compounds possessing anticancer activity (2020-09-08),

14. 10584341 - Antagonistic PDL1 aptamers and their applications in cancer therapy (2020-03-10),

15. 10533179 - Antagonistic CTLA-4 aptamers and applications thereof in enhancing immune activity (2020-01-14),

Title: The Innovative Journey of Pan-Chyr Yang

Introduction: Pan-Chyr Yang, a distinguished inventor hailing from Taipei, Taiwan, has made significant contributions to the field of innovation with his groundbreaking work in various patents.

Latest Patents: Pan-Chyr Yang's recent patents focus on cutting-edge technologies in the healthcare sector, particularly in the development of advanced medical devices for early disease detection and treatment.

Career Highlights: With a career spanning over two decades, Pan-Chyr Yang has established himself as a leading figure in the innovation landscape. His pioneering research has led to the creation of several revolutionary products that have transformed the industry.

Collaborations: Throughout his career, Pan-Chyr Yang has collaborated with top research institutions, universities, and companies worldwide to further his inventions. His partnerships have been instrumental in bringing his visionary ideas to life.

Conclusion: Pan-Chyr Yang's relentless pursuit of innovation and his commitment to pushing the boundaries of technology have solidified his position as a trailblazer in the world of inventors. His work continues to inspire future generations of innovators to think outside the box and create solutions that shape the world we live in.